[Sacubitril/valsartan (heart failure, children and adolescents) – Addendum to Commission A23-56]

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018005388
German
Original Title: Sacubitril/Valsartan (Herzinsuffizienz, Kinder und Jugendliche) - Addendum zum Projekt A23-56 (Dossierbewertung)
Details
Project Status: Completed
URL for project: https://www.iqwig.de/projekte/a23-103.html
Year Published: 2023
URL for published report: https://www.iqwig.de/download/a23-103_sacubitril-valsartan_addendum-zum-projekt-a23-56_v1-0.pdf
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
DOI: https://dx.doi.org/10.60584/A23-103
MeSH Terms
  • Heart Failure
  • Child
  • Adolescent
  • Drug Combinations
  • Valsartan
  • Angiotensin Receptor Antagonists
Keywords
  • Sacubitril
  • Valsartan
  • Heart Failure
  • Child - Preschool
  • Child
  • Adolescent
  • Benefit Assessment
  • NCT02678312
Contact
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.